Companies wager high on CD38-targeting drugs for blood cancer.
- Published in:
- Nature Medicine, 2012, v. 18, n. 10, p. 1446, doi. 10.1038/nm1012-1446a
- By:
- Publication type:
- Article
Works matching DE "JANSSEN Biotech Inc."
Results: 8
1
2
Janssen CarePath.
- Published in:
- 2018
- Publication type:
- Product Review
3
Drug & therapeutics update.
- Published in:
- 2013
- Publication type:
- Product Review
4
Drugging the gut microbiome.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 3, p. 228, doi. 10.1038/nbt.3161
- By:
- Publication type:
- Article
5
Antibody patent claims tighten.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 8, p. 707, doi. 10.1038/nbt0814-707b
- Publication type:
- Article
6
Companies in rapid pursuit of Btk immunokinase.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 3, p. 199, doi. 10.1038/nbt0312-199
- By:
- Publication type:
- Article
7
FDA Approves Yesintek, Sixth Stelara Biosimilar; Launch Slated for February.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 24
- Publication type:
- Article
8
From the Alabama Supreme Court.
- Published in:
- Alabama Lawyer, 2020, v. 81, n. 1, p. 92
- By:
- Publication type:
- Article